A centenarian is a person who has attained the age of 100 years or more. Research on centenarians has become more common with clinical and general population studies now having been conducted in France, Hungary, Japan, Italy, Finland, Denmark, the United States, and China. [1] Centenarians are the second fastest-growing demographic in much of the developed world. [2] By 2030, it is expected that there will be around a million centenarians worldwide. [3] In the United States, a 2010 Census Bureau report found that more than 80 percent of centenarians are women. [4]
Research carried out in Italy suggests that healthy centenarians have high levels of vitamin A and vitamin E and that this seems to be important in guaranteeing their extreme longevity. [5] Other research contradicts this and has found that these findings do not apply to centenarians from Sardinia, for whom other factors probably play a more important role. [6] A preliminary study carried out in Poland showed that, in comparison with young healthy female adults, centenarians living in Upper Silesia had significantly higher red blood cell glutathione reductase and catalase activities and higher, although insignificantly, serum levels of vitamin E. [7] Researchers in Denmark have also found that centenarians exhibit a high activity of glutathione reductase in red blood cells. In this study, those centenarians having the best cognitive and physical functional capacity tended to have the highest activity of this enzyme. [8]
Some research suggests that high levels of vitamin D may be associated with longevity. [9]
Other research has found that people having parents who became centenarians have an increased number of naïve B cells. [10]
It is believed that centenarians possess a different adiponectin isoform pattern and have a favorable metabolic phenotype in comparison with elderly individuals. [11]
Research carried out in the United States has found that people are much more likely to celebrate their 100th birthday if their brother or sister has reached the age. [12] These findings, from the New England Centenarian Study in Boston, suggest that the sibling of a centenarian is four times more likely to live past 90 than the general population. [13] Other research carried out by the New England Centenarian Study has identified 150 genetic variations that appeared to be associated with longevity which could be used to predict with 77 percent accuracy whether someone would live to be at least 100. [14]
Research also suggests that there is a clear link between living to 100 and inheriting a hyperactive version of telomerase, an enzyme that prevents cells from ageing. Scientists from the Albert Einstein College of Medicine in the US say centenarian Ashkenazi Jews have this mutant gene. [15]
Many centenarians manage to avoid chronic diseases even after indulging in a lifetime of serious health risks. For example, many people in the New England Centenarian Study experienced a century free of cancer or heart disease despite smoking as many as 60 cigarettes a day for 50 years. The same applies to people from Okinawa in Japan, where around half of supercentenarians had a history of smoking and one-third were regular alcohol drinkers. It is possible that these people may have had genes that protected them from the dangers of carcinogens or the random mutations that crop up naturally when cells divide. [16]
Similarly, centenarian research carried out at the Albert Einstein College of Medicine found that the individuals studied had less than sterling health habits. As a group, for example, they were more obese, more sedentary and exercised less than other, younger cohorts. The researchers also discovered three uncommon genotype similarities among the centenarians: one gene that causes HDL cholesterol to be at levels two- to three-fold higher than average; another gene that results in a mildly underactive thyroid; and a functional mutation in the human growth hormone axis that may be a safeguard from aging-associated diseases. [17]
It is well known that the children of parents who have a long life are also likely to reach a healthy age, but it is not known why, although the inherited genes are probably important. [18] A variation in the gene FOXO3 is known to have a positive effect on the life expectancy of humans, and is found much more often in people living to 100 and beyond – moreover, this appears to be true worldwide. [19]
Some research suggests that centenarian offspring are more likely to age in better cardiovascular health than their peers. [20]
A 2011 study found people with exceptional longevity (aged 95 and older) not to be distinct from the general population in terms of lifestyle factors such as regular physical activity, diet or alcohol consumption. [21]
A study indicates gut microbiomes with large amounts of microbes capable of generating unique secondary bile acids are a key element of centenarians' longevity. [22] [23]
Several studies have shown that centenarians have better cardiovascular risk profiles compared to younger old people. The contribution of drug treatments to promote extreme longevity is not confirmed and centenarians in general have needed fewer drugs at younger ages due to a healthy lifestyle. [24] A study by the International Longevity Centre-UK, published in 2011, suggested that today's centenarians may be healthier than the next generation of centenarians. [25]
Ninety percent of the centenarians studied in the New England Centenarian Study were functionally independent the vast majority of their lives up until the average age of 92 years and 75% were the same at an average age of 95 years. [26] Similarly, a study of US supercentenarians (age 110 to 119 years) showed that, even at these advanced ages, 40% needed little assistance or were independent. [27]
A study supported by the US National Institute on Aging found significant associations between month of birth and longevity, with individuals born in September–November having a higher likelihood of becoming centenarians compared to March-born individuals. [28]
In the United States, a 2010 Census Bureau report found that more than 80 percent of centenarians are women. [29]
In 2024, Saul Justin Newman published a pre-print paper finding that supercentenarians and extreme age records tend to come from areas with no birth certificates, rampant clerical errors, pension fraud, and short life spans. The study argues that document validation, the only method that demographics use to verify old age, is susceptible to errors that have often been ignored due to confirmation bias and other factors, causing inflated number of valid cases. This suggests that many figures of supercentenarians' population, and studies that rely on those populations, may contain significant errors that have yet to reassessed critically. [30] The study was awarded with the Ig Nobel Prize in 2024. [31]
Human life expectancy is a statistical measure of the estimate of the average remaining years of life at a given age. The most commonly used measure is life expectancy at birth. This can be defined in two ways. Cohort LEB is the mean length of life of a birth cohort and can be computed only for cohorts born so long ago that all their members have died. Period LEB is the mean length of life of a hypothetical cohort assumed to be exposed, from birth through death, to the mortality rates observed at a given year. National LEB figures reported by national agencies and international organizations for human populations are estimates of period LEB.
Life extension is the concept of extending the human lifespan, either modestly through improvements in medicine or dramatically by increasing the maximum lifespan beyond its generally-settled biological limit of around 125 years. Several researchers in the area, along with "life extensionists", "immortalists", or "longevists", postulate that future breakthroughs in tissue rejuvenation, stem cells, regenerative medicine, molecular repair, gene therapy, pharmaceuticals, and organ replacement will eventually enable humans to have indefinite lifespans through complete rejuvenation to a healthy youthful condition (agerasia). The ethical ramifications, if life extension becomes a possibility, are debated by bioethicists.
A centenarian is a person who has reached the age of 100 years. Because life expectancies worldwide are below 100, the term is invariably associated with longevity. The United Nations estimated that there were 316,600 living centenarians worldwide in 2012, and 573,000 in 2020, almost quadruple the 2000 estimate of 151,000.
Longevity may refer to especially long-lived members of a population, whereas life expectancy is defined statistically as the average number of years remaining at a given age. For example, a population's life expectancy at birth is the same as the average age at death for all people born in the same year.
Maximum life span is a measure of the maximum amount of time one or more members of a population have been observed to survive between birth and death. The term can also denote an estimate of the maximum amount of time that a member of a given species could survive between birth and death, provided circumstances that are optimal to that member's longevity.
A supercentenarian, sometimes hyphenated as super-centenarian, is a person who is 110 years or older. This age is achieved by about one in 1,000 centenarians. Supercentenarians typically live a life free of significant age-related diseases until shortly before the maximum human lifespan is reached.
Hendrikje van Andel-Schipper was a Dutch supercentenarian who lived to the age of 115 years, 62 days. She is the oldest person ever from the Netherlands, breaking the previous record of Catharina van Dam on 26 September 2003, and from 29 May 2004 was thought to be the oldest verified person in the world. She became the oldest living person in the Netherlands on 16 February 2001, at the age of 110 years and 232 days.
Biogerontology is the sub-field of gerontology concerned with the biological aging process, its evolutionary origins, and potential means to intervene in the process. The term "biogerontology" was coined by S. Rattan, and came in regular use with the start of the journal Biogerontology in 2000. It involves interdisciplinary research on the causes, effects, and mechanisms of biological aging. Biogerontologist Leonard Hayflick has said that the natural average lifespan for a human is around 92 years and, if humans do not invent new approaches to treat aging, they will be stuck with this lifespan. James Vaupel has predicted that life expectancy in industrialized countries will reach 100 for children born after the year 2000. Many surveyed biogerontologists have predicted life expectancies of more than three centuries for people born after the year 2100. Other scientists, more controversially, suggest the possibility of unlimited lifespans for those currently living. For example, Aubrey de Grey offers the "tentative timeframe" that with adequate funding of research to develop interventions in aging such as strategies for engineered negligible senescence, "we have a 50/50 chance of developing technology within about 25 to 30 years from now that will, under reasonable assumptions about the rate of subsequent improvements in that technology, allow us to stop people from dying of aging at any age". The idea of this approach is to use presently available technology to extend lifespans of currently living humans long enough for future technological progress to resolve any remaining aging-related issues. This concept has been referred to as longevity escape velocity.
Vitamin D toxicity, or hypervitaminosis D, is the toxic state of an excess of vitamin D. The normal range for blood concentration of 25-hydroxyvitamin D in adults is 20 to 50 nanograms per milliliter (ng/mL). Blood levels necessary to cause adverse effects in adults are thought to be greater than about 150 ng/mL, leading the Endocrine Society to suggest an upper limit for safety of 100 ng/mL.
The Okinawa Centenarian Study is a study of the elderly people of Okinawa, Japan. The study, funded by Japan's ministry of health, is the largest of its kind ever carried out. Over the years, the scientists involved have had access to more than 600 Okinawan centenarians.
A blue zone is a region in the world where people are claimed to have exceptionally long lives beyond the age of 80 due to a lifestyle combining physical activity, low stress, rich social interactions, a local whole-foods diet, and low disease incidence. Examples of blue zones include Okinawa Prefecture, Japan; Nuoro Province, Sardinia, Italy; the Nicoya Peninsula, Costa Rica; and Icaria, Greece. The name "blue zones" derived simply during the original survey by scientists, who "used a blue pen on a map to mark the villages with long-lived population."
The Gerontology Research Group (GRG) based in Los Angeles, California, US, is a global non-profit scientific organization of researchers in various fields of gerontology, primarily concerned with validating the ages of, recording and researching supercentenarians.
Aging in dogs varies from breed to breed, and affects the dog's health and physical ability. As with humans, advanced years often bring changes in a dog's ability to hear, see, and move about easily. Skin condition, appetite, and energy levels often degrade with geriatric age. Medical conditions such as cancer, kidney failure, arthritis, dementia, and joint conditions, and other signs of old age may appear.
The New England Centenarian Study is a study of persons aged 100 and over (centenarians) in the Boston area.
Thomas Perls is the founding director of the New England Centenarian Study, the longest-running largest study of centenarians and their family members in the world. The Study is worldwide in scope but most of the participants come from the United States and Canada and is funded by three National Institute on Aging grants: The Integrative Longevity Omics Study, Centenarian Project of the Longevity Consortium and the Long Life Family Study. The study is also funded, with great appreciation, by the William M. Wood Foundation and the Paulette and Marty Samowitz Foundation. Born in Palo Alto, California, Perls later moved to Colorado and now lives in Boston. He received his B.A. from Pitzer College in 1982, his M.D. from the University of Rochester School of Medicine and Dentistry in 1986, and his M.P.H. from Harvard University in 1993. Perls is Professor of medicine at Boston University School of Medicine and attending physician in geriatrics at Boston Medical Center. He is the author of over 160 peer-reviewed articles primarily in biodemography and genetics of exceptional human longevity and anti-aging quackery.
Genetics of aging is generally concerned with life extension associated with genetic alterations, rather than with accelerated aging diseases leading to reduction in lifespan.
Nir Barzilai is an Israeli geneticist and longevity researcher.
Arthur Roger Thatcher was a British statistician. Thatcher was born in Birmingham and spent his formative early years in Wilmslow, Cheshire. He attended The Leys School in Cambridge and went on to university at St John's College, Cambridge, where he concentrated his studies in statistics, economics, and mathematics. After brief training in meteorology as part of his national service, he instructed Royal Navy pilots in weather patterns. He married his wife Mary in 1950; they had two children.
Recent human evolution refers to evolutionary adaptation, sexual and natural selection, and genetic drift within Homo sapiens populations, since their separation and dispersal in the Middle Paleolithic about 50,000 years ago. Contrary to popular belief, not only are humans still evolving, their evolution since the dawn of agriculture is faster than ever before. It has been proposed that human culture acts as a selective force in human evolution and has accelerated it; however, this is disputed. With a sufficiently large data set and modern research methods, scientists can study the changes in the frequency of an allele occurring in a tiny subset of the population over a single lifetime, the shortest meaningful time scale in evolution. Comparing a given gene with that of other species enables geneticists to determine whether it is rapidly evolving in humans alone. For example, while human DNA is on average 98% identical to chimp DNA, the so-called Human Accelerated Region 1 (HAR1), involved in the development of the brain, is only 85% similar.
This timeline lists notable events in the history of research into senescence or biological aging, including the research and development of life extension methods, brain aging delay methods and rejuvenation.